US Stock Market Movement: Tempus AI soared on October 28 as AI-driven pharmaceutical R&D and medical data AI sectors strengthened
Bitget异动解读2026/10/28 17:40Tempus AI October 28th Surge Explained
Keywords: AI drug development sector strengthening, medical data AI
On October 28th, AI drug discovery-related stocks generally rose, with Schrödinger up around 11%, Recursion up about 9%, and Tempus AI up 7.02%. The Nasdaq 100 Index and the Russell 2000 Index both increased by around 1%. Reports described the day's trend as an overall rebound in risk appetite driving strength in related stocks.
(Disclaimer: This content is summarized from publicly available information using AI technology and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Microsoft Capital Expenditure Falls Short! "Compute Landlords" See Collective Decline in After-Hours Stock Prices
Although Azure's cloud computing revenue increased by 48% year-on-year, Microsoft's capital expenditure fell short of market expectations. This has raised concerns that their cloud infrastructure partners, such as CRWV.US and Nebius(NBIS.US) data centers, may experience slower capacity delivery progress.
Petrobras achieves record-high output in Q3, refineries operate near full capacity
Crypto prices
More
